Genetic determinants of methotrexate treatment in rheumatoid arthritis patients: a study of polymorphisms in the adenosine pathway.

Genetic determinants of methotrexate treatment in rheumatoid arthritis patients: a study of polymorphisms in the adenosine pathway.

Item
http://www.wikidata.org/entity/Q43088332
Influence of folate pathway polymorphisms on high-dose methotrexate-related toxicity and survival in childhood acute lymphoblastic leukemia.ABCB1 genetic variants in leukemias: current insights into treatment outcomesMarkers of treatment response to methotrexate in rheumatoid arthritis: where do we stand?Polymorphisms in the ABCB1 gene and effect on outcome and toxicity in childhood acute lymphoblastic leukemiaMethotrexate pharmacogenetics in rheumatoid arthritis: a status report.Three decades of low-dose methotrexate in rheumatoid arthritis: can we predict toxicity?Association of the ATIC 347 C/G polymorphism with responsiveness to and toxicity of methotrexate in rheumatoid arthritis: a meta-analysis.Are gene polymorphisms related to treatment outcomes of methotrexate in patients with rheumatoid arthritis? A systematic review and meta-analysis.Genetic variation in the SLC19A1 gene and methotrexate toxicity in rheumatoid arthritis patients.Moving toward personalized medicine in rheumatoid arthritis: SNPs in methotrexate intracellular pathways are associated with methotrexate therapeutic outcome.ATIC 347C>G gene polymorphism may be associated with methotrexate-induced adverse events in south Indian Tamil rheumatoid arthritis.Genetic variation in genes involved in folate and drug metabolism in a south Indian population.Clinical Pharmacogenetic Models of Treatment Response to Methotrexate Monotherapy in Slovenian and Serbian Rheumatoid Arthritis Patients: Differences in Patient's Management May Preclude Generalization of the Models.Risk factors for abnormal hepatic enzyme elevation by methotrexate treatment in patients with rheumatoid arthritis: A hospital based-cohort study.Clinical-pharmacogenetic predictive models for MTX discontinuation due to adverse events in rheumatoid arthritis.
P2860

Genetic determinants of methotrexate treatment in rheumatoid arthritis patients: a study of polymorphisms in the adenosine pathway.

Item
http://www.wikidata.org/entity/Q43088332
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Genetic determinants of methot ...... isms in the adenosine pathway.
@en
Genetic determinants of methot ...... isms in the adenosine pathway.
@nl
type
label
Genetic determinants of methot ...... isms in the adenosine pathway.
@en
Genetic determinants of methot ...... isms in the adenosine pathway.
@nl
prefLabel
Genetic determinants of methot ...... isms in the adenosine pathway.
@en
Genetic determinants of methot ...... isms in the adenosine pathway.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
Genetic determinants of methot ...... isms in the adenosine pathway.
@en
P2093
P304
P31
P356
P407
P433
P478
P577
P698